JL Boormans
Erasmus Universiteit Rotterdam
H-index: 35
Europe-Netherlands
Top articles of JL Boormans
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Proton beam therapy for hepatocellular carcinoma: Multicenter prospective registry study in Japan | International Journal of Radiation Oncology* Biology* Physics | Masashi Mizumoto Hiroyuki Ogino Toshiyuki Okumura Kazuki Terashima Masao Murakami | 2024/3/1 |
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer | Journal of Clinical Oncology | Niklas Klümper Ngoc Khanh Tran Stefanie Zschäbitz Oliver Hahn Thomas Büttner | 2024/4 |
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy | European Urology Open Science | Florus C de Jong Iris G Ifle Angelique C van der Made Denise Kooper Joep J de Jong | 2024/4/1 |
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer | Nature Communications | Maud Rijnders J Alberto Nakauma-González Debbie GJ Robbrecht Alberto Gil-Jimenez Hayri E Balcioglu | 2024/2/14 |
Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers | Urologic Oncology: Seminars and Original Investigations | Moritz J Reike Joep J de Jong Tarek A Bismar Stephen A Boorjian Omar Y Mian | 2024/3/12 |
Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 … | European urology open science | Thomas van Doeveren Sebastiaan Remmers Vera Atema Roderick CN van den Bergh Egbert R Boevé | 2024/2/1 |
Disease progression in Bacillus Calmètte Guerin unresponsive non-muscle invasive bladder cancer patients with carcinoma in situ, participating in clinical trials on bladder … | Translational Andrology and Urology | Olga M Pijpers Joost L Boormans | 2024/3/3 |
PD20-07 ONCOLOGIC OUTCOMES IN PATIENTS WITH VARIANT HISTOLOGIES OF UPPER TRACT UROTHELIAL CANCER: RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT | The Journal of Urology | Maximilian Pallauf Sean A Fletcher Michael Rezaee Morgan Rouprêt Stephen A Boorjian | 2024/5 |
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy | European Urology Oncology | Sean A Fletcher Maximilian Pallauf Emelia K Watts Kara A Lombardo Jack A Campbell | 2024/1/22 |
A deep‐learning workflow to predict upper tract urothelial carcinoma protein‐based subtypes from H&E slides supporting the prioritization of patients for molecular testing | The Journal of Pathology: Clinical Research | Miriam Angeloni Thomas van Doeveren Sebastian Lindner Patrick Volland Jorina Schmelmer | 2024/3 |
Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature | Cell Genomics | J Alberto Nakauma-González Maud Rijnders Minouk TW Noordsij John WM Martens Astrid AM van der Veldt | 2023 |
Disease-free survival of patients with muscle-invasive bladder cancer treated with radical cystectomy versus bladder-preserving therapy: a nationwide study | International Journal of Radiation Oncology* Biology* Physics | Katharina Brück Richard P Meijer Joost L Boormans Lambertus A Kiemeney J Alfred Witjes | 2024/1/1 |
Diagnostic accuracy of clinical lymph node staging for upper tract urothelial cancer patients: a multicenter, retrospective, observational study | The Journal of urology | Maximilian Pallauf David D’Andrea Frederik König Ekaterina Laukhtina Takafumi Yanagisawa | 2023/3 |
Middellangetermijnoverleving na open versus robotgeassisteerde radicale cystectomie in Nederland: resultaten van de ‘SNAPSHOT’cystectomie | Tijdschrift voor Urologie | Noor van Ginkel André N Vis Joost L Boormans Henk G van der Poel Deric KE van der Schoot | 2023/12 |
MP63-05 OUTCOMES IN PATIENTS (PTS) WITH BACILLUS CALMETTE-GUERIN (BCG)-UNRESPONSIVE HIGH-RISK (HR) NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC) WHO UNDERWENT RADICAL CYSTECTOMY … | The Journal of Urology | Girish S Kulkarni Ashish M Kamat Edward M Uchio Mathieu Roumiguié Laurence EM Krieger | 2023/4 |
Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the … | Frontiers in oncology | CF Stockem JJJ Mellema BWG van Rhijn TN Boellaard ML van Montfoort | 2023/8/29 |
Pembrolizumab (pembro) monotherapy for patients (pts) with high-risk non–muscle-invasive bladder cancer (HR NMIBC) unresponsive to bacillus Calmette–Guérin (BCG): Results from … | Andrea Necchi Mathieu Roumiguié Ahmet Adil Esen Thierry Lebret Ronald De Wit | 2023/2/20 | |
A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testing | medRxiv | Miriam Angeloni Thomas van Doeveren Sebastian Lindner Patrick Volland Jorina Schmelmer | 2023 |
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer | Cancer Immunology, Immunotherapy | Maud Rijnders Debbie GJ Robbrecht Astrid AM Oostvogels Mandy van Brakel Joost L Boormans | 2023/3 |
PD36-02 A COMPOSITE BIOMARKER APPROACH TO SPARE NEOADJUVANT CHEMOTHERAPY IN SELECT MUSCLE-INVASIVE BLADDER CANCER PATIENTS | The Journal of Urology | Joep De Jong A Gordon Robertson Nick Beije John Martens Ellen Zwarthoff | 2023/4 |
